POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.22.2021, 12:50pm CEST, WHO):   India 53,256    Brazil 44,178    France 1,815    Turkey 5,091    Russia 17,378    The United Kingdom 9,072    Argentina 10,395    Columbia 27,818    Iran 10,485    Mexico 1,578    Peru 2,896    Indonesia 14,536    South Africa 13,155    Chile 5,205    Philippines 5,249    Iraq 5,235    Bangladesh 4,636    Japan 1,011    Malaysia 4,611    Nepal 1,584    United Arab Emirates 1,964    Saudi Arabia 1,212    Bolivia 1,086    Paraguay 1,145    Tunisia 2,478    Uruguay 1,488    Kuwait 1,935    Venezuela 1,327    Oman 2,529    Thailand 3,175    Cuba 1,561    Zambia 2,060    Afghanistan 1,847    Mongolia 2,268    Namibia 1,403    Uganda 1,367    China 103    Singapore 16    New Zealand 0    Australia 25    South Korea 395   

Russia says people immunized with Sputnik V will need another vaccine

Christian Fernsby |
Russian Deputy Health Minister Oleg Gridnev said on Tuesday that people who have been immunized with Sputnik V vaccine against Covid-19 might need another vaccine after some time.

Article continues below

Speaking at the State Duma (Lower House of the Russian Parliament), Gridnev noted that the country has other vaccines besides Sputnik V and increasing their production is as positive, TASS news agency reported.

He added that Russian scientists predict that after one year 'a revaccination might be needed, with a vaccine other than Sputnik V', which can be CoviVac or EpiVacCorona, the two other Russia-made vaccines, 'but the research in this field is still underway.'

He added that the industrial production of Sputnik V is much higher at present, so its distribution and shipments in Russia are also larger.

The Russian deputy health minister also explained to the lawmakers that, according to studies, the single-dose Sputnik Light vaccine has had good results in the development of an immune response in young people.

What to read next

Russia approves single-dose 'Sputnik Light' COVID-19 vaccine
World-first COVID-19 alternating dose vaccine study launches in UK
New vaccine to provide 2-year protection